These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36094938)

  • 1. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
    Derbie A; Amare B; Misgan E; Nibret E; Maier M; Woldeamanuel Y; Abebe T
    PLoS One; 2022; 17(9):e0274466. PubMed ID: 36094938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia.
    Derbie A; Maier M; Amare B; Misgan E; Nibret E; Liebert UG; Woldeamanuel Y; Abebe T
    Infect Agent Cancer; 2023 Jan; 18(1):4. PubMed ID: 36703179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
    Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
    BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design.
    Worku E; Yigizaw G; Admassu R; Mekonnen D; Gessessa W; Tessema Z; Walle T
    BMC Womens Health; 2024 Jun; 24(1):322. PubMed ID: 38834999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
    BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Tesfaye E; Kumbi B; Mandefro B; Hemba Y; Prajapati KK; Singh SC; Upadhye V; Hajare ST
    Sci Rep; 2024 Feb; 14(1):4053. PubMed ID: 38374354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
    Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
    Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
    [No Abstract]   [Full Text] [Related]  

  • 12. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.
    Feng RM; Z Wang M; Smith JS; Dong L; Chen F; Pan QJ; Zhang X; Qiao YL; Zhao FH
    J Clin Virol; 2018; 99-100():84-90. PubMed ID: 29396352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega, West Ethiopia, 2022.
    Ephrem Dibisa K; Tamiru Dinka M; Mekonen Moti L; Fetensa G
    Cancer Control; 2022; 29():10732748221117900. PubMed ID: 35947527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of precancerous cervical lesions: The role of women's socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study.
    Taye BT; Mihret MS; Muche HA
    PLoS One; 2021; 16(3):e0249218. PubMed ID: 33770125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
    Anderson JR; Yogeshkumar S; Lu E; Yenokyan G; Thaler K; Mensa M; Chikaraddi S; Lokare L; Gudadinni MR; Antartani R; Donimath K; Patil B; Bidri S; Goudar SS; Derman R; Dalal A;
    BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):158-167. PubMed ID: 37932903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study.
    Gedefaw A; Astatkie A; Tessema GA
    PLoS One; 2013; 8(12):e84519. PubMed ID: 24376818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
    Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
    BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.